Michael Aaron Kelly - 01 Jun 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
01 Jun 2024
Transactions value $
$0
Form type
4
Date filed
04 Jun 2024, 16:09
Previous filing
15 May 2024
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NEO Common Stock 20.4K 01 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +8.67K $0.00 8.67K 01 Jun 2024 Common Stock 8.67K $13.71 Direct
transaction NEO Restricted Stock Unit Award $0 +12.3K $0.00 12.3K 01 Jun 2024 Common Stock 12.3K $0.00 Direct F1
holding NEO Stock Option (Right to Buy) 2.22K 01 Jun 2024 Common Stock 2.22K $37.53 Direct
holding NEO Stock Option (Right to Buy) 3.71K 01 Jun 2024 Common Stock 3.71K $40.90 Direct
holding NEO Stock Option (Right to Buy) 13.9K 01 Jun 2024 Common Stock 13.9K $8.10 Direct
holding NEO Stock Option (Right to Buy) 8.35K 01 Jun 2024 Common Stock 8.35K $14.82 Direct
holding NEO Restricted Stock Unit 11.3K 01 Jun 2024 Common Stock 11.3K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Once vested, the shares of common stock are not subject to expiration.